Guangxi Zhuang Autonomous Region Brain Hospital, Guangxi Liuzhou, 545005, China.
Department of Psychosomatic Disorders, Shenzhen Mental Health Center/Shenzhen KangNing Hospital, Shenzhen, 518000, Guangdong, China.
BMC Psychiatry. 2023 Jan 4;23(1):10. doi: 10.1186/s12888-022-04511-z.
Patients with dyslipidemia are at increased risk for suicide, especially those with major depressive disorder (MDD). Few studies have investigated the independent effects of suicide attempts on comorbid dyslipidemia in patients with MDD. Moreover, there are no comparisons of differences in factors associated with suicide attempts among patients with MDD with dyslipidemia at different ages of onset. The aim of this study was to investigate the prevalence of suicide attempts and associated variables in first episode and untreated patients with MDD with comorbid dyslipidemia at different ages of onset.
We recruited 1718 patients with first-episode untreated MDD in this study. Demographical and clinical data were collected, and lipid profiles, thyroid function, and blood glucose levels were measured. The Hamilton Depression Scale 17 (HAMD-17), Hamilton Anxiety Scale (HAMA), Clinical Global Impression Severity Scale (CGI), and Positive and Negative Syndrome Scale (PANSS) positive subscale were assessed for depression, anxiety and illness severity, as well as psychotic symptoms, respectively.
The percentage of patients with MDD with comorbid dyslipidemia was 61% (1048/1718). Among patients with MDD with comorbid dyslipidemia, the incidence of suicide attempts was 22.2% (170/765) for early adulthood onset and 26.5% (75/283) for mid-adulthood onset. Independent factors associated with suicide attempts in early adulthood onset patients with MDD with dyslipidemia were as follows: HAMA score (B = 0.328, P < 0.0001, OR = 1.388), Suspicion /persecution (B = -0.554, P = 0.006, OR = 0.575), CGI (B = 0.878, P < 0.0001, OR = 2.406), systolic blood pressure (B = 0.048, P = 0.004, OR = 1.049), hallucinatory behavior (B = 0.334, P = 0.025, OR = 1.397), and TPOAb (B = 0.003, p < 0.0001, OR = 1.003). Independent factors associated with suicide attempts in mid-adulthood onset patients with MDD with comorbid dyslipidemia were as follows: HAMA score (B = 0.182, P < 0.0001, OR = 1.200), CGI (B = 1.022, P < 0.0001, OR = 2.778), and TPOAb (B = 0.002, P = 0.009, OR = 1.002).
Our findings suggest an elevated risk of suicide attempts in patients with MDD with comorbid dyslipidemia. The incidence of suicide attempts was similar in the early- and mid-adulthood onset subgroups among patients with MDD with dyslipidemia, but the factors associated with suicide attempts were different in these two subgroups.
患有血脂异常的患者自杀风险增加,尤其是患有重性抑郁障碍(MDD)的患者。很少有研究调查自杀尝试对 MDD 合并血脂异常患者的独立影响。此外,对于不同发病年龄的血脂异常 MDD 患者中与自杀尝试相关的因素之间的差异,尚无比较。本研究旨在调查不同发病年龄血脂异常的首发和未经治疗的 MDD 患者自杀尝试的发生率及其相关变量。
我们招募了 1718 例首发未经治疗的 MDD 患者参与本研究。收集人口统计学和临床数据,并测量血脂谱、甲状腺功能和血糖水平。使用 17 项汉密尔顿抑郁量表(HAMD-17)、汉密尔顿焦虑量表(HAMA)、临床总体印象严重程度量表(CGI)和阳性和阴性症状量表(PANSS)阳性分量表评估抑郁、焦虑和疾病严重程度以及精神病症状。
MDD 合并血脂异常患者的比例为 61%(1048/1718)。在 MDD 合并血脂异常的患者中,血脂异常的 MDD 患者的自杀尝试发生率为早发组的 22.2%(765 例中的 170 例)和中年组的 26.5%(283 例中的 75 例)。血脂异常的早发 MDD 患者发生自杀尝试的独立相关因素如下:HAMA 评分(B=0.328,P<0.0001,OR=1.388)、怀疑/迫害(B=-0.554,P=0.006,OR=0.575)、CGI(B=0.878,P<0.0001,OR=2.406)、收缩压(B=0.048,P=0.004,OR=1.049)、幻觉行为(B=0.334,P=0.025,OR=1.397)和 TPOAb(B=0.003,P<0.0001,OR=1.003)。血脂异常的中年 MDD 患者发生自杀尝试的独立相关因素如下:HAMA 评分(B=0.182,P<0.0001,OR=1.200)、CGI(B=1.022,P<0.0001,OR=2.778)和 TPOAb(B=0.002,P=0.009,OR=1.002)。
我们的研究结果表明,血脂异常的 MDD 患者自杀风险增加。血脂异常的 MDD 患者中,早发组和中年组自杀尝试的发生率相似,但两组中与自杀尝试相关的因素不同。